Replies to post #23502 on BioSante Pharmaceuticals, Inc. (BPAX)

[Jeffqdh]

There will be no adjustment to the total number of shares of BioSante common stock that ANI stockholders will be entitled to receive as a result of changes in the market price of BioSante common stock. Accordingly, the market value of the shares of BioSante common stock issued in connection with the merger will depend on the market value of the shares of BioSante common stock at the time of the

 

20

Table of Contents


merger, and could vary significantly from the market value on the date of this joint proxy statement/prospectus.